Name: Zinc acetate dihydrate
SKU: 5970-45-6

Products Categories

Pharmaceutical (108)
Organic Chemicals (49)
Others (40)
Reagent (14)
Food Additives (14)
Agrochemicals (7)
Catalyst and Auxiliary (3)
Basic Inorganic Chemicals (3)
Materials (2)

Basic Information

Molecular Structure:
CAS No.:	5970-45-6
Name:	Zinc acetate dihydrate

Formula:	C₄H₁₀O₆Zn
Molecular Weight:	219.51
Synonyms:	Aceticacid, zinc salt, dihydrate (8CI,9CI);Wilzin;Zincdiacetate dihydrate;
EINECS:	209-170-2
Density:	1.145 g/cm³
Melting Point:	100 °C
Boiling Point:	117.1 °C at 760 mmHg
Flash Point:	40 °C
Solubility:	430 g/L (20 °C) in water
Appearance:	Colourless or white efflorescent crystals
Hazard Symbols:	Xn,N
Risk Codes:	22-36-50/53
Safety:	26-60-61-36
Transport Information:	UN 3077 9/PG 3
PSA:	98.72000
LogP:	-2.61870

Synthetic route

: 64-19-7
acetic acid

: 743369-26-8
zinc(II) carbonate

: 5970-45-6
zinc(II) acetate dihydrate

Conditions

Conditions	Yield
In water prepn. by gradual addition of carboxylic acid to water soln. of ZnCO3; soln. stirred; soln. reduced in vol. at 70°C in water bath; left to crystallize at room temp.; filtered off; washed (Et2O); dried at room temp.; elem. anal.;

: 557-34-6
zinc diacetate

: 5970-45-6
zinc(II) acetate dihydrate

Conditions

Conditions	Yield
With water In water react. in warm water;;
With water on storing in moist air for 14 days;;
With H2O on storing in moist air for 14 days;;
With H2O In water react. in warm water;;

: zinc(II) acetate * 0.5 acetic acid

: 5970-45-6
zinc(II) acetate dihydrate

Conditions

Conditions	Yield
With water
With H2O

: 1455-77-2
guanazole

: 5970-45-6
zinc(II) acetate dihydrate

Conditions

Conditions	Yield
In N,N-dimethyl-formamide

: 5970-45-6
zinc(II) acetate dihydrate

: 134469-07-1
Benzimidazol-2-thiol

: 14220-38-3
zinc bis(benzimidazole-2-thiolate)

Conditions

Conditions	Yield
With KOH In ethanol; water heated until become homogenous; allowed to cool, precipitate filtered off, washed with ethanol, dried in vac.;	100%

: 5970-45-6
zinc(II) acetate dihydrate

: 96-53-7
2-mercaptothiazoline

: zinc bis(thiazoline-2-thiolate)

Conditions

Conditions	Yield
With KOH In ethanol; water heated until become homogenous; allowed to cool, precipitate filtered off, washed with ethanol, dried in vac.;	100%

: H2C20H8N4(C6H2(CH3)3)2(C6H4I)2

: 5970-45-6
zinc(II) acetate dihydrate

: 247069-50-7
zinc 5,15-dimesityl-10,20-bis(3-iodophenyl)porphyrin

Conditions

Conditions	Yield
In methanol stirring (room temp., overnight); washing (NaHCO3 and H2O), drying (Na2SO4), filtration, concentration;	100%

: lithium tetrafluoroborate

: [[((CHC5H2N(C6H4OC2H4OC2H4O))2C6H3(C(C4H2N(C(C6H3(C4H9)2))3C4H2N)Au)][(C6H3NC6H4C((C2C(CH3)C(C6H13)N)2CHZn)2C(C14H21))2](PF6)

: 5970-45-6
zinc(II) acetate dihydrate

: [[((CHC5H2N(C6H4OC2H4OC2H4O))2C6H3(C(C4H2N(C(C6H3(C4H9)2))3C4H2N)Au)]Li[(C6H3NC6H4C((C2C(CH3)C(C6H13)N)2CHZn)2C(C14H21))2](PF6)2

Conditions

Conditions	Yield
In methanol; dichloromethane; water under Ar; to a soln. of the complex in CH2Cl2 was added a soln. of LiBF4in CH3OH, the mixt. was stirred for 2 h; the solvent was evapd.;	100%

...Expand

: 4-[zinc(II) 10,15,20-triphenyl-5-porphinyl]-4'-[10,15,20-triphenyl-5-porphinyl]-3,5,3',5'-tetrachlorodiphenylethyne

: 5970-45-6
zinc(II) acetate dihydrate

: 4,4'-bis[zinc(II) 10,15,20-triphenyl-5-porphinyl]-3,5,3',5'-tetrachlorodiphenylethyne

Conditions

Conditions	Yield
In methanol; dichloromethane stirring porphyrin (in CH2Cl2) with excess Zn(OAc)2 (in MeOH) at room temp. overnight; solvent removal (vac.), chromy. (SiO2, hexanes/CH2Cl2=3:2);	100%

: C20H4N4(CH3)4(C6H4OCH2CH2SH)2((CH2)5CH3)4

: 5970-45-6
zinc(II) acetate dihydrate

: 850620-67-6
[Zn(C20H2N4(CH3)4(C6H4OCH2CH2SCOCH3)2((CH2)5CH3)4)]

Conditions

Conditions	Yield
In chloroform at 50°C;	100%

Total:167 Page 1 of 5 1 2 3 4 5 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 5970-45-6

Consensus Reports

Zinc and its compounds are on the Community Right-To-Know List.

Specification

The Zinc acetate, dihydrate with the cas number 5970-45-6, is also called zinc diacetate named by IUPAC. And it's systemic name are (1) Acetic acid, zinc salt, dihydrate; (2) Zinc(II) acetate dihydrate. It belongs to the following product categories: (1)Organic-metal salt; (2)ACS GradeChemical Synthesis; (3)Essential Chemicals; (4)Routine Reagents; (5)Catalysis and Inorganic Chemistry; (6)Chemical Synthesis; (7)Zinc; (8)Micro/Nanoelectronics; (9)Solution Deposition Precursors; (10)Analytical Reagents for General Use; (11)Puriss p.a. ACS; (12)T-Z, Puriss p.a. ACSChemical Synthesis. It seems like Colourless or white efflorescent crystals, stable but incompatible with alkalies, strong oxidizing agents.

Physical properties about this chemical are: Physical properties about this chemical are: (1)ACD/LogP: -0.29; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.07; (4)ACD/LogD (pH 7.4): -2.86; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 2.73; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 0; (12)Polar Surface Area: 37.3 Å²; (13)Flash Point: 40 °C; (14)Enthalpy of Vaporization: 23.7 kJ/mol; (15)Boiling Point: 117.1 °C at 760 mmHg; (16)Vapour Pressure: 13.9 mmHg at 25°C.

Uses of Zinc acetate, dihydrate: It can be used to treat zinc deficiencies. As an oral daily supplement, Zinc acetate, dihydrate is used to inhibit the body's absorption of copper that is the part of the treatment for Wilson's disease. In addition, Zinc acetate, dihydrate, is also sold as an astringent in the form of an ointment, a topical lotion; or combined with an antibiotic such as erythromycin for the topical treatment of acne. Furthermore, Zinc acetate, dihydrate is commonly sold as a topical anti-itch ointment. What's more, Zinc acetate, dihydrate is also used as a dietary supplement and in lozenges used to treat the common cold. It is thought that the treatment of Zinc acetate, dihydrate alone is more effective that zinc gluconate. Besides,the industrial applications of Zinc acetate include wood preserving, manufacturing other zinc salts, polymers, manufacture of ethylene acetate, as a dye mordant, and analytical reagent. More important, Zinc acetate is known as a precursor via a sol-gel route to the transparent semiconductor zinc oxide.

When you are using this chemical, please be cautious about it as the following: It is quite irritating to eyes, and harmful if swallowed. Before you are using it, please wear suitable protective clothing. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. It is Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Hence, avoid release to the environment. Refer to special instructions / safety data sheets. Most of important, this material and its container must be disposed of as hazardous waste.

You can still convert the following datas into molecular structure :
(1).SMILES: [Zn+2].[O-]C(=O)C.[O-]C(=O)C.O.O
(2).InChI:InChI=1/2C2H4O2.2H2O.Zn/c2*1-2(3)4;;;/h2*1H3,(H,3,4);2*1H2;/q;;;;+2/p-2

Toxic information of Zinc acetate, dihydrate can be showed as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	108mg/kg (108mg/kg)		Archives of Toxicology. Vol. 61, Pg. 321, 1988.
mouse	LD50	oral	287mg/kg (287mg/kg)	SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Veterinary and Human Toxicology. Vol. 30, Pg. 224, 1988.
rat	LD50	intraperitoneal	162mg/kg (162mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION	Veterinary and Human Toxicology. Vol. 30, Pg. 224, 1988.
rat	LD50	oral	794mg/kg (794mg/kg)	SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION	Veterinary and Human Toxicology. Vol. 30, Pg. 224, 1988.

5970-45-6

Refine

Country

Business Type

Certificate

Display

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

5970-45-6

Consensus Reports

Specification